Differential Impact of GLP-1R and GIP Signalling on Cardiovascular Disease Risk: Insights from MVP- and UKB-Based GWAS Data (Supplement dataset)

1. Outcome

Heart failure (n=1,708,342)  http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90728001-GCST90729000/GCST90728695/

Atrial fibrillation (n=1,840,341) http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90624001-GCST90625000/GCST90624412/

large artery stroke (n=1,241,207) http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90104001-GCST90105000/GCST90104542/

coronary artery disease (n=1,165,690) http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90132001-GCST90133000/GCST90132314/

Peripheral Artery Disease (n=321,302) https://storage.googleapis.com/finngen-public-data-r7/summary_stats/finngen_R7_I9_PAD.gz

Venous Thrombus Embolism (n=500,348)  https://storage.googleapis.com/finngen-public-data-r12/summary_stats/release/finngen_R12_I9_VTE.gz

2. Expoure

UK biobank: http://www.nealelab.is/uk-biobank

MVP: https://www.ebi.ac.uk/gwas/publications/39024449